Latest news with #CBUS
Yahoo
3 days ago
- Business
- Yahoo
Cibus says USDA designates HT2 as ‘not regulated' under biotech regulations
Cibus (CBUS) announced that its most recent trait for its herbicide tolerance trait in Canola has been designated as 'not regulated' by the United States Department of Agriculture's Animal and Plant Health Inspection Service Biotechnology Regulatory Services as Plant Pests or Which There is Reason to Believe Are Plant Pests, as described in 7 CFR part 340. Consistent with other Cibus developed and advanced traits developed utilizing Cibus' Rapid Trait Development System, this most recent USDA-APHIS regulatory determination, along with others recently announced, brings Cibus' total number of traits designated as not regulated to seventeen. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders' Hot Stocks on TipRanks >> Read More on CBUS: Disclaimer & DisclosureReport an Issue Cibus Stock (CBUS) Plummets 30% on Public Offering Pricing Morning News Wrap-Up: Thursday's Biggest Stock Market Stories Cibus prices 15.7M shares at $1.75 in public offering Cibus Announces Strategic Realignment to Streamline Operations Cibus announces Class A common stock offering, no amount given
Washington Post
08-05-2025
- Business
- Washington Post
Cibus: Q1 Earnings Snapshot
SAN DIEGO — SAN DIEGO — Cibus, Inc. (CBUS) on Thursday reported a loss of $46.9 million in its first quarter. On a per-share basis, the San Diego-based company said it had a loss of $1.34. Losses, adjusted for asset impairment costs, were 74 cents per share. The developer and licensor of plant traits for seed companies posted revenue of $1 million in the period. In the final minutes of trading on Thursday, the company's shares hit $2.35. A year ago, they were trading at $17.35. _____ This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on CBUS at
